4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0000899243-21-034143
EVP, Chief Financial Officer sold 22,667 shares at $60.51 ($1,371,580)
- EVP, Chief Financial Officer acquired 22,667 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Burke William P. Mr. EVP, Chief Financial Officer | 2021-08-23 | Option exercise | +11,232 | $34.21 | $384,247 | 41,523 | D |
| Burke William P. Mr. EVP, Chief Financial Officer | 2021-08-23 | Option exercise | +11,435 | $41.64 | $476,153 | 52,958 | D |
| Burke William P. Mr. EVP, Chief Financial Officer | 2021-08-23 | Sale | −22,667 | $60.51 | $1,371,580 | 30,291 | D |
| Derivatives | |||||||
| Burke William P. Mr. EVP, Chief Financial Officer | 2021-08-23 | Option exercise · Non-qualified Stock Option (Right to Buy) | −11,232 | 0 | D | ||
| Burke William P. Mr. EVP, Chief Financial Officer | 2021-08-23 | Option exercise · Non-qualified Stock Option (Right to Buy) | −11,435 | 0 | D | ||
| Open-market sales · 22,667 sh · avg $60.51 · $1,371,580 | |||||||
Loading xslF345X03/doc4.xml…